Does TNF have anti-osteoclastogenic actions?

Annals of the New York Academy of Sciences

Volumn 1068, Issue 1, 2006, Pages 234-239

  Iqbal, Jameel ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Inhibition; M CSF; Osteoclast; RANKL; TNF

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BIOLOGICAL MARKER; CATHEPSIN K; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL TISSUE; CELL DIFFERENTIATION; CONFERENCE PAPER; CONTROLLED STUDY; MACROPHAGE; MOUSE; NONHUMAN; OSTEOCLAST; PROTEIN EXPRESSION; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE;

ANIMALIA;

EID: 33744751797     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1346.056     Document Type: Conference Paper

References (13)

1. Beutler, B. & A. Cerami. 1988. Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response. Endocr. Rev. 9 : 57 66.
2. Carswell, E.A., L.J. Old, R.L. Kassel, et al. 1975. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72 : 3666 3670.
3. Fong, Y., S.F. Lowry, & A. Cerami. 1988. Cachetin/TNF: a macrophage protein that induces cachexia and shock. JPEN J. Parenter. Enteral Nutr. 12 : 72S 77S.
4. Simonet, W.S., D.L. Lacey, C.R. Dunstan, et al. 1997. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89 : 309 319.
5. Lacey, D.L., E. Timms, H.L. Tan, et al. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 : 165 176.
6. Fuller, K., C. Murphy, B. Kirstein, et al. 2002. TNFalpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 143 : 1108 1118.
7. Lam, J., S. Takeshita, J.E. Barker, et al. 2000. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest. 106 : 1481 1488.
8. Abu-Amer, Y., S. Abbas & T. Hirayama. 2004. TNF receptor type 1 regulates RANK ligand expression by stromal cells and modulates osteoclastogenesis. J. Cell Biochem. 93 : 980 989.
9. Kitaura, H., M.S. Sands, K. Aya, et al. 2004. Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo. J. Immunol. 173 : 4838 4846.
10. Bucay, N., I. Sarosi, C.R. Dunstan, et al. 1998. Osteoprotegerin- deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12 : 1260 1268.
11. Komine, M., A. Kukita, T. Kukita, et al. 2001. Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture. Bone 28 : 474 483.
12. Abu-Amer, Y., J. Erdmann, L. Alexopoulou, et al. 2000. Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis. J. Biol. Chem. 275 : 27307 27310.
13. Zhang, Y.H., A. Heulsmann, M.M. Tondravi, et al. 2001. Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J. Biol. Chem. 276 : 563 568.